A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T Cells

Sherly Mardiana; Liza B John; Melissa A Henderson; Clare Y Slaney; Bianca von Scheidt; Lauren Giuffrida; Alexander J Davenport; Joseph A Trapani; Paul J Neeson; Sherene Loi; Nicole M Haynes; Michael H Kershaw; Paul A Beavis; Phillip K Darcy

Journal article

A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T Cells

Sherly Mardiana, Liza B John, Melissa A Henderson, Clare Y Slaney, Bianca von Scheidt, Lauren Giuffrida, Alexander J Davenport, Joseph A Trapani, Paul J Neeson, Sherene Loi, Nicole M Haynes, Michael H Kershaw, Paul A Beavis, Phillip K Darcy

Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2017

DOI: 10.1158/0008-5472.CAN-16-1831

University of Melbourne Researchers

Phillip Darcy Author The Sir Peter MacCallum Department of Oncology

Clare Slaney Author The Sir Peter MacCallum Department of Oncology

Sherene Loi Author The Sir Peter MacCallum Department of Oncology

Paul Neeson Author The Sir Peter MacCallum Department of Oncology

Nicole Haynes Author The Sir Peter MacCallum Department of Oncology

Related Projects (3)

TARGETING THE ADENOSINE PATHWAY FOR ENHANCING CANCER THERAPY

We have shown that drugs that block immunosuppressive adenosine receptors can improve anti-tumour immune responses and consequently enhance ..

USING THE IMMUNE SYSTEM AGAINST CANCER

My goal is to boost the immune system against cancer to develop new therapies. I aim to do this by genetically engineering the immune system..

UTILIZATION OF GENE-ENGINEERED T CELLS FOR ENHANCING CANCER IMMUNOTHERAPY

Killer T lymphocytes can penetrate tumours and their transfer into cancer patients has demonstrated some encouraging results, but this form ..

Grants

Awarded by National Health and Medical Research Council (NHMRC)

Awarded by Cancer Council Victoria project

Awarded by National Breast Cancer Foundation fellowships

Awarded by NHMRC senior research fellowships

Awarded by National Breast Cancer Foundation

Funding Acknowledgements

This work was funded by a project and program grant from the National Health and Medical Research Council (NHMRC; grant number 1062580) and a Cancer Council Victoria project grant (APP1084420). P.A. Beavis and C.Y. Slaney were supported by National Breast Cancer Foundation fellowships (PF-14-008 and ECF-16-005). P.K. Darcy and M.H. Kershaw were supported by NHMRC senior research fellowships (APP1041828 and APP1058388).